Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 107 | 2024 | 4242 | 7.430 |
Why?
|
Transplantation Tolerance | 38 | 2023 | 620 | 7.290 |
Why?
|
Transplantation Chimera | 40 | 2022 | 594 | 6.690 |
Why?
|
Bone Marrow Transplantation | 42 | 2022 | 2692 | 4.670 |
Why?
|
Graft Survival | 50 | 2024 | 3843 | 3.540 |
Why?
|
Chimerism | 12 | 2023 | 155 | 3.470 |
Why?
|
Transplantation Conditioning | 25 | 2022 | 1591 | 3.020 |
Why?
|
Graft Rejection | 51 | 2024 | 4481 | 2.800 |
Why?
|
Immune Tolerance | 32 | 2023 | 2307 | 2.740 |
Why?
|
Macaca fascicularis | 48 | 2023 | 901 | 2.550 |
Why?
|
Immunosuppressive Agents | 32 | 2024 | 4190 | 1.470 |
Why?
|
HLA Antigens | 11 | 2019 | 1331 | 1.410 |
Why?
|
Kidney Failure, Chronic | 20 | 2024 | 2478 | 1.350 |
Why?
|
Transplantation, Homologous | 38 | 2022 | 4822 | 1.230 |
Why?
|
Organ Transplantation | 10 | 2022 | 1165 | 1.170 |
Why?
|
Histocompatibility Testing | 18 | 2020 | 716 | 1.100 |
Why?
|
Islets of Langerhans Transplantation | 4 | 2019 | 743 | 1.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 9 | 2023 | 5666 | 0.960 |
Why?
|
Living Donors | 8 | 2021 | 643 | 0.950 |
Why?
|
Isoantibodies | 12 | 2020 | 675 | 0.910 |
Why?
|
Primates | 9 | 2023 | 521 | 0.880 |
Why?
|
Immunologic Memory | 8 | 2017 | 1361 | 0.810 |
Why?
|
Kidney | 19 | 2024 | 7033 | 0.810 |
Why?
|
Histocompatibility | 4 | 2018 | 319 | 0.780 |
Why?
|
Liver Transplantation | 17 | 2023 | 2332 | 0.770 |
Why?
|
Transplantation, Heterologous | 14 | 2024 | 2381 | 0.750 |
Why?
|
Antibodies, Monoclonal | 15 | 2023 | 9187 | 0.620 |
Why?
|
Tissue Donors | 13 | 2023 | 2335 | 0.600 |
Why?
|
Nephrectomy | 4 | 2012 | 938 | 0.600 |
Why?
|
Major Histocompatibility Complex | 10 | 2020 | 872 | 0.600 |
Why?
|
CD40 Ligand | 6 | 2023 | 524 | 0.590 |
Why?
|
Interleukin-2 | 3 | 2015 | 1891 | 0.570 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2019 | 3092 | 0.530 |
Why?
|
Animals | 92 | 2024 | 168079 | 0.530 |
Why?
|
Transplantation Immunology | 4 | 2015 | 537 | 0.520 |
Why?
|
Renal Dialysis | 9 | 2022 | 1796 | 0.510 |
Why?
|
Hypertension | 6 | 2016 | 8536 | 0.480 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2012 | 15 | 0.420 |
Why?
|
T-Lymphocytes | 15 | 2015 | 10203 | 0.410 |
Why?
|
Organ Preservation | 7 | 2024 | 382 | 0.400 |
Why?
|
Models, Animal | 8 | 2019 | 2115 | 0.400 |
Why?
|
Hematopoiesis | 2 | 2019 | 2046 | 0.400 |
Why?
|
Ultrasonography, Doppler | 2 | 2011 | 462 | 0.390 |
Why?
|
Adaptation, Physiological | 2 | 2010 | 1301 | 0.390 |
Why?
|
Graft Occlusion, Vascular | 3 | 2022 | 537 | 0.390 |
Why?
|
Immunotoxins | 1 | 2012 | 175 | 0.390 |
Why?
|
Diphtheria Toxin | 1 | 2012 | 253 | 0.380 |
Why?
|
Polytetrafluoroethylene | 2 | 2011 | 245 | 0.370 |
Why?
|
Vascular Resistance | 2 | 2011 | 933 | 0.370 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2022 | 290 | 0.370 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2018 | 4574 | 0.370 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1600 | 0.340 |
Why?
|
Stem Cell Factor | 1 | 2010 | 195 | 0.330 |
Why?
|
Swine | 10 | 2024 | 5909 | 0.330 |
Why?
|
Antilymphocyte Serum | 8 | 2015 | 491 | 0.320 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.320 |
Why?
|
Carotid Arteries | 1 | 2013 | 941 | 0.320 |
Why?
|
Brain Death | 5 | 2023 | 357 | 0.320 |
Why?
|
Multiple Myeloma | 4 | 2019 | 5145 | 0.310 |
Why?
|
Lymphocele | 1 | 2008 | 19 | 0.310 |
Why?
|
Recombinant Fusion Proteins | 4 | 2013 | 3726 | 0.300 |
Why?
|
Killer Cells, Natural | 2 | 2012 | 2194 | 0.300 |
Why?
|
Kidney Diseases | 4 | 2014 | 2092 | 0.300 |
Why?
|
Blood Vessel Prosthesis | 3 | 2011 | 951 | 0.290 |
Why?
|
Islets of Langerhans | 5 | 2003 | 1342 | 0.290 |
Why?
|
Histocompatibility Antigens | 2 | 2020 | 467 | 0.290 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 629 | 0.280 |
Why?
|
Splenectomy | 8 | 2010 | 391 | 0.270 |
Why?
|
RNA, Messenger | 3 | 2019 | 12747 | 0.270 |
Why?
|
Uric Acid | 1 | 2012 | 807 | 0.260 |
Why?
|
Whole-Body Irradiation | 9 | 2009 | 432 | 0.260 |
Why?
|
Carotid Stenosis | 1 | 2013 | 859 | 0.260 |
Why?
|
Cyclosporine | 8 | 2015 | 776 | 0.250 |
Why?
|
Humans | 107 | 2024 | 761208 | 0.250 |
Why?
|
Renal Insufficiency | 1 | 2011 | 808 | 0.240 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 3025 | 0.240 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 373 | 0.240 |
Why?
|
Male | 78 | 2024 | 360693 | 0.230 |
Why?
|
Follow-Up Studies | 16 | 2020 | 39126 | 0.230 |
Why?
|
Vascular Patency | 5 | 2022 | 911 | 0.230 |
Why?
|
Papio | 4 | 2024 | 669 | 0.230 |
Why?
|
Lymphatic Vessels | 1 | 2008 | 356 | 0.220 |
Why?
|
Liver Failure, Acute | 2 | 2018 | 181 | 0.220 |
Why?
|
Brachial Artery | 2 | 2017 | 366 | 0.220 |
Why?
|
Animals, Genetically Modified | 3 | 2024 | 1558 | 0.210 |
Why?
|
Lymphocyte Depletion | 8 | 2010 | 602 | 0.210 |
Why?
|
Transplantation | 2 | 1995 | 221 | 0.210 |
Why?
|
Neutropenia | 1 | 2008 | 885 | 0.210 |
Why?
|
Time Factors | 21 | 2019 | 39957 | 0.210 |
Why?
|
Genes, bcl-2 | 1 | 2023 | 119 | 0.210 |
Why?
|
Perfusion | 5 | 2024 | 1390 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 2 | 2015 | 3388 | 0.210 |
Why?
|
Galactosyltransferases | 1 | 2024 | 276 | 0.210 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 877 | 0.210 |
Why?
|
Cyclophosphamide | 1 | 2008 | 2219 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 7 | 2017 | 6486 | 0.200 |
Why?
|
Cell Separation | 3 | 2003 | 1721 | 0.200 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2293 | 0.200 |
Why?
|
Tissue and Organ Procurement | 5 | 2021 | 963 | 0.200 |
Why?
|
Clinical Protocols | 2 | 2020 | 1436 | 0.190 |
Why?
|
Kidney Function Tests | 4 | 2015 | 680 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2014 | 4372 | 0.190 |
Why?
|
Postoperative Complications | 13 | 2019 | 15637 | 0.190 |
Why?
|
Skin Transplantation | 3 | 2020 | 1091 | 0.180 |
Why?
|
Renin | 1 | 2023 | 639 | 0.180 |
Why?
|
User-Computer Interface | 1 | 2007 | 1393 | 0.180 |
Why?
|
Clinical Trials as Topic | 4 | 2022 | 8003 | 0.180 |
Why?
|
Glomerular Filtration Rate | 4 | 2015 | 2182 | 0.180 |
Why?
|
Cyclosporins | 9 | 1990 | 216 | 0.170 |
Why?
|
End Stage Liver Disease | 2 | 2023 | 352 | 0.170 |
Why?
|
Expert Testimony | 1 | 2022 | 365 | 0.170 |
Why?
|
Immunologic Techniques | 1 | 1999 | 212 | 0.170 |
Why?
|
Lung Transplantation | 3 | 2015 | 1307 | 0.170 |
Why?
|
GATA3 Transcription Factor | 1 | 2019 | 155 | 0.160 |
Why?
|
Blood Pressure | 2 | 2011 | 8479 | 0.160 |
Why?
|
Stroke | 4 | 2014 | 9721 | 0.160 |
Why?
|
Japan | 5 | 2016 | 1378 | 0.160 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4309 | 0.160 |
Why?
|
Retrospective Studies | 24 | 2023 | 80674 | 0.160 |
Why?
|
Atherosclerosis | 2 | 2013 | 3406 | 0.160 |
Why?
|
Middle Aged | 37 | 2023 | 220853 | 0.160 |
Why?
|
Heat Stroke | 1 | 2018 | 29 | 0.150 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2003 | 1116 | 0.150 |
Why?
|
Renal Circulation | 3 | 2011 | 291 | 0.150 |
Why?
|
Female | 53 | 2024 | 392544 | 0.150 |
Why?
|
Thromboembolism | 2 | 2004 | 992 | 0.140 |
Why?
|
ABO Blood-Group System | 5 | 2009 | 381 | 0.140 |
Why?
|
Isoantigens | 3 | 2015 | 559 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2019 | 1613 | 0.140 |
Why?
|
B-Lymphocytes | 4 | 2017 | 4744 | 0.140 |
Why?
|
Graft vs Host Reaction | 1 | 1997 | 99 | 0.140 |
Why?
|
Pancreas Transplantation | 3 | 1995 | 197 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2012 | 15520 | 0.140 |
Why?
|
Liver | 8 | 2022 | 7514 | 0.130 |
Why?
|
Flow Cytometry | 8 | 2012 | 5871 | 0.130 |
Why?
|
Haplorhini | 3 | 2009 | 523 | 0.130 |
Why?
|
Liver Failure | 1 | 2018 | 250 | 0.130 |
Why?
|
Immunoglobulin G | 5 | 2023 | 4537 | 0.130 |
Why?
|
Treatment Outcome | 18 | 2022 | 64681 | 0.130 |
Why?
|
Delayed Graft Function | 2 | 2012 | 53 | 0.120 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.120 |
Why?
|
Radial Artery | 1 | 2017 | 187 | 0.120 |
Why?
|
Vascular Diseases | 2 | 2022 | 1160 | 0.120 |
Why?
|
Mice | 12 | 2024 | 81326 | 0.120 |
Why?
|
Clonal Deletion | 1 | 2015 | 74 | 0.120 |
Why?
|
Bone Marrow | 4 | 2020 | 2911 | 0.120 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2015 | 56 | 0.120 |
Why?
|
Heart Transplantation | 4 | 2002 | 3258 | 0.120 |
Why?
|
Death | 2 | 2010 | 677 | 0.120 |
Why?
|
Thymus Gland | 4 | 2007 | 1243 | 0.120 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 232 | 0.110 |
Why?
|
Creatinine | 6 | 2012 | 1897 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2019 | 1176 | 0.110 |
Why?
|
Adult | 37 | 2023 | 221119 | 0.110 |
Why?
|
Risk Factors | 11 | 2023 | 74239 | 0.110 |
Why?
|
Hyperoxaluria, Primary | 1 | 2013 | 24 | 0.110 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 163 | 0.110 |
Why?
|
Angioplasty, Balloon | 1 | 2017 | 589 | 0.110 |
Why?
|
Th1 Cells | 1 | 2018 | 1042 | 0.100 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2014 | 534 | 0.100 |
Why?
|
Ureterostomy | 1 | 2012 | 18 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15308 | 0.100 |
Why?
|
Veins | 1 | 2017 | 767 | 0.100 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 426 | 0.100 |
Why?
|
Hepatitis C | 3 | 2020 | 1579 | 0.100 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2014 | 263 | 0.100 |
Why?
|
Cystostomy | 1 | 2012 | 25 | 0.100 |
Why?
|
Protein S Deficiency | 1 | 2011 | 13 | 0.100 |
Why?
|
Hypertension, Malignant | 1 | 2012 | 17 | 0.100 |
Why?
|
Genotype | 2 | 2019 | 12985 | 0.100 |
Why?
|
Membrane Glycoproteins | 2 | 2000 | 3696 | 0.100 |
Why?
|
Survival Rate | 6 | 2013 | 12728 | 0.100 |
Why?
|
Myeloablative Agonists | 1 | 2013 | 209 | 0.100 |
Why?
|
Mannose | 5 | 1990 | 121 | 0.100 |
Why?
|
Muromonab-CD3 | 2 | 1996 | 104 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 658 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 1963 | 0.100 |
Why?
|
Immunoconjugates | 1 | 1999 | 963 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1027 | 0.100 |
Why?
|
Capillary Leak Syndrome | 1 | 2011 | 34 | 0.090 |
Why?
|
Interleukin-15 | 1 | 2012 | 185 | 0.090 |
Why?
|
Aged | 16 | 2019 | 169288 | 0.090 |
Why?
|
Prognosis | 5 | 2020 | 29687 | 0.090 |
Why?
|
Cattle | 2 | 2015 | 3818 | 0.090 |
Why?
|
Learning Curve | 1 | 2012 | 230 | 0.090 |
Why?
|
Portal Vein | 1 | 2013 | 432 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6304 | 0.090 |
Why?
|
Leukocyte Count | 4 | 2011 | 1597 | 0.090 |
Why?
|
Organ Specificity | 1 | 2015 | 1963 | 0.090 |
Why?
|
C-Peptide | 2 | 2003 | 442 | 0.090 |
Why?
|
4-Aminobenzoic Acid | 5 | 1990 | 22 | 0.090 |
Why?
|
Leukapheresis | 1 | 2010 | 134 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 54435 | 0.080 |
Why?
|
Ureter | 1 | 2012 | 368 | 0.080 |
Why?
|
Ankle | 1 | 2012 | 350 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2017 | 2549 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13632 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2011 | 244 | 0.080 |
Why?
|
Blood Substitutes | 4 | 1992 | 57 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 2012 | 633 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1567 | 0.080 |
Why?
|
Cadaver | 2 | 2008 | 1358 | 0.080 |
Why?
|
Proteinuria | 1 | 2011 | 605 | 0.080 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 637 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3571 | 0.080 |
Why?
|
Lymphatic Irradiation | 1 | 2008 | 115 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6819 | 0.080 |
Why?
|
Biopsy | 4 | 2008 | 6781 | 0.080 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1375 | 0.070 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2008 | 164 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1895 | 0.070 |
Why?
|
Blood Coagulation Disorders | 2 | 2000 | 350 | 0.070 |
Why?
|
Arteriosclerosis | 1 | 2011 | 1056 | 0.070 |
Why?
|
History, 20th Century | 1 | 2015 | 2765 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18220 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1063 | 0.070 |
Why?
|
Granzymes | 1 | 2008 | 276 | 0.070 |
Why?
|
Blood Group Incompatibility | 2 | 1998 | 135 | 0.070 |
Why?
|
Cytomegalovirus Infections | 3 | 2017 | 828 | 0.070 |
Why?
|
Thrombolytic Therapy | 1 | 2015 | 2055 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2410 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2012 | 1303 | 0.060 |
Why?
|
Biocompatible Materials | 2 | 2011 | 1683 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1425 | 0.060 |
Why?
|
Nephritis, Hereditary | 1 | 2006 | 78 | 0.060 |
Why?
|
Cohort Studies | 3 | 2013 | 41496 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2075 | 0.060 |
Why?
|
Postoperative Care | 1 | 1992 | 1468 | 0.060 |
Why?
|
Plasmacytoma | 1 | 2006 | 171 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2013 | 3155 | 0.060 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2015 | 509 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2017 | 10422 | 0.060 |
Why?
|
ROC Curve | 1 | 2012 | 3584 | 0.060 |
Why?
|
Haplotypes | 1 | 2011 | 2715 | 0.060 |
Why?
|
Tissue Preservation | 3 | 1992 | 174 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1910 | 0.060 |
Why?
|
Adoptive Transfer | 1 | 2007 | 823 | 0.060 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1923 | 0.060 |
Why?
|
Swine, Miniature | 2 | 2023 | 961 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 20588 | 0.060 |
Why?
|
Blood Vessels | 2 | 1999 | 1111 | 0.060 |
Why?
|
Age Factors | 3 | 2016 | 18384 | 0.060 |
Why?
|
Aging | 2 | 2016 | 8702 | 0.060 |
Why?
|
Foundations | 1 | 2024 | 95 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1419 | 0.050 |
Why?
|
Hepatic Encephalopathy | 2 | 2012 | 143 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1996 | 585 | 0.050 |
Why?
|
Asia | 2 | 1995 | 622 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12474 | 0.050 |
Why?
|
Disaccharides | 1 | 2003 | 170 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2011 | 6223 | 0.050 |
Why?
|
Serum Albumin, Bovine | 1 | 2003 | 319 | 0.050 |
Why?
|
Chimera | 3 | 1999 | 453 | 0.050 |
Why?
|
Radiology Information Systems | 1 | 2007 | 529 | 0.050 |
Why?
|
Preoperative Care | 1 | 1992 | 2241 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1157 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3691 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2019 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2640 | 0.050 |
Why?
|
Registries | 2 | 2014 | 8247 | 0.050 |
Why?
|
Intestine, Small | 3 | 1992 | 1207 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 801 | 0.050 |
Why?
|
Thrombophilia | 1 | 2004 | 306 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8519 | 0.050 |
Why?
|
Lymph Nodes | 3 | 2009 | 3461 | 0.050 |
Why?
|
Cytokines | 1 | 2015 | 7386 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1221 | 0.040 |
Why?
|
Patient Selection | 3 | 2022 | 4246 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2004 | 0.040 |
Why?
|
Transgenes | 1 | 2023 | 1008 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10756 | 0.040 |
Why?
|
Plasmapheresis | 2 | 1998 | 207 | 0.040 |
Why?
|
Mice, Inbred CBA | 1 | 2020 | 438 | 0.040 |
Why?
|
Laparoscopy | 2 | 2009 | 2035 | 0.040 |
Why?
|
Thrombosis | 3 | 2000 | 2944 | 0.040 |
Why?
|
Boston | 3 | 2017 | 9327 | 0.040 |
Why?
|
Hepatectomy | 2 | 2020 | 557 | 0.040 |
Why?
|
Prostaglandins | 3 | 1989 | 398 | 0.040 |
Why?
|
Waiting Lists | 1 | 2024 | 766 | 0.040 |
Why?
|
Pennsylvania | 1 | 2020 | 612 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Hemoglobins | 3 | 1992 | 1525 | 0.040 |
Why?
|
Alprostadil | 2 | 2004 | 86 | 0.040 |
Why?
|
Horses | 2 | 2015 | 296 | 0.040 |
Why?
|
Disease Progression | 2 | 2014 | 13511 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6199 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1097 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1936 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6988 | 0.040 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 531 | 0.040 |
Why?
|
Child | 11 | 2022 | 80152 | 0.040 |
Why?
|
Stents | 2 | 2022 | 3177 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2023 | 803 | 0.040 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2017 | 57 | 0.040 |
Why?
|
Antibodies | 2 | 2022 | 2415 | 0.040 |
Why?
|
Antibody Formation | 3 | 1997 | 1391 | 0.040 |
Why?
|
Blood Glucose | 2 | 2003 | 6392 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21365 | 0.040 |
Why?
|
Spleen | 1 | 2003 | 2290 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2011 | 5842 | 0.030 |
Why?
|
Polysaccharides | 1 | 2023 | 1014 | 0.030 |
Why?
|
Clinical Competence | 1 | 2012 | 4788 | 0.030 |
Why?
|
Dogs | 6 | 1992 | 3832 | 0.030 |
Why?
|
Platelet Activation | 1 | 2000 | 646 | 0.030 |
Why?
|
Medication Adherence | 1 | 2008 | 2175 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3245 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 1999 | 918 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9278 | 0.030 |
Why?
|
Mice, Nude | 1 | 2003 | 3605 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 1999 | 5478 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15721 | 0.030 |
Why?
|
Antiviral Agents | 2 | 2020 | 3048 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14610 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 614 | 0.030 |
Why?
|
Neutrophils | 1 | 2008 | 3763 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2017 | 18926 | 0.030 |
Why?
|
Antigens, Viral | 2 | 1997 | 989 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 781 | 0.030 |
Why?
|
Adolescent | 14 | 2014 | 88298 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15920 | 0.030 |
Why?
|
Survival Analysis | 2 | 1999 | 10088 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6505 | 0.030 |
Why?
|
Polyethylene Glycols | 2 | 1992 | 1187 | 0.030 |
Why?
|
Complementarity Determining Regions | 1 | 2015 | 149 | 0.030 |
Why?
|
Health Care Costs | 1 | 2007 | 3239 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2000 | 1156 | 0.030 |
Why?
|
Chronic Disease | 5 | 2011 | 9319 | 0.030 |
Why?
|
Antigens, CD | 2 | 2007 | 4009 | 0.030 |
Why?
|
Thromboxane B2 | 2 | 1991 | 143 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8642 | 0.030 |
Why?
|
Family | 2 | 1995 | 3192 | 0.030 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 672 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10516 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30002 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2014 | 199 | 0.030 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 1997 | 335 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 3803 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 224 | 0.030 |
Why?
|
Young Adult | 3 | 2014 | 59221 | 0.030 |
Why?
|
Oxalates | 1 | 2013 | 98 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 799 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 1997 | 6067 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1330 | 0.030 |
Why?
|
Tacrolimus | 1 | 1996 | 736 | 0.030 |
Why?
|
Protein S | 1 | 2011 | 29 | 0.020 |
Why?
|
Epoprostenol | 3 | 1988 | 248 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14675 | 0.020 |
Why?
|
Interferon-alpha | 1 | 1996 | 907 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.020 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2011 | 65 | 0.020 |
Why?
|
Organ Preservation Solutions | 1 | 1992 | 100 | 0.020 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1991 | 80 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 697 | 0.020 |
Why?
|
Rats, Inbred Lew | 4 | 1996 | 1159 | 0.020 |
Why?
|
Rats, Inbred Strains | 5 | 1990 | 2087 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 126 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3551 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 362 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 1991 | 289 | 0.020 |
Why?
|
Device Removal | 1 | 2015 | 629 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2112 | 0.020 |
Why?
|
Insulin | 3 | 2001 | 6588 | 0.020 |
Why?
|
Parathyroidectomy | 1 | 1992 | 242 | 0.020 |
Why?
|
Lymphatic System | 1 | 1991 | 253 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3418 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2014 | 1994 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2012 | 324 | 0.020 |
Why?
|
Intracranial Hypertension | 1 | 2012 | 193 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11067 | 0.020 |
Why?
|
Polyurethanes | 1 | 1989 | 109 | 0.020 |
Why?
|
Complement C4b | 1 | 2009 | 125 | 0.020 |
Why?
|
Life Expectancy | 1 | 2016 | 1242 | 0.020 |
Why?
|
Hepatitis Viruses | 1 | 1988 | 15 | 0.020 |
Why?
|
Walking | 1 | 2016 | 1194 | 0.020 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1988 | 42 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2011 | 12159 | 0.020 |
Why?
|
International Cooperation | 1 | 1995 | 1423 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2599 | 0.020 |
Why?
|
Carpal Tunnel Syndrome | 1 | 1992 | 303 | 0.020 |
Why?
|
Europe | 1 | 1995 | 3423 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1992 | 767 | 0.020 |
Why?
|
Thromboxane-A Synthase | 1 | 1987 | 34 | 0.020 |
Why?
|
Macaca mulatta | 1 | 1994 | 2328 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2009 | 399 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 1991 | 771 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2011 | 1334 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3603 | 0.020 |
Why?
|
Acrylates | 1 | 1987 | 75 | 0.020 |
Why?
|
Gabexate | 1 | 1987 | 12 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2011 | 416 | 0.020 |
Why?
|
Pyridoxal Phosphate | 1 | 1987 | 120 | 0.020 |
Why?
|
alpha-Cyclodextrins | 1 | 1987 | 12 | 0.020 |
Why?
|
Methacrylates | 1 | 1987 | 109 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2981 | 0.020 |
Why?
|
Acute Disease | 3 | 2002 | 7226 | 0.020 |
Why?
|
Rats | 9 | 1996 | 23704 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1867 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2016 | 58952 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2007 | 448 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1993 | 1783 | 0.020 |
Why?
|
Methylprednisolone | 3 | 1996 | 386 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 1992 | 973 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 944 | 0.020 |
Why?
|
Resource Allocation | 1 | 2007 | 350 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2509 | 0.020 |
Why?
|
Portal System | 2 | 1997 | 49 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15841 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1996 | 3149 | 0.010 |
Why?
|
Logistic Models | 2 | 2016 | 13249 | 0.010 |
Why?
|
Ketorolac Tromethamine | 1 | 2004 | 21 | 0.010 |
Why?
|
Immune System | 1 | 2009 | 792 | 0.010 |
Why?
|
Phosphates | 1 | 1987 | 763 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1597 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9652 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2726 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1992 | 1201 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4027 | 0.010 |
Why?
|
Signal Transduction | 2 | 2011 | 23416 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1997 | 2949 | 0.010 |
Why?
|
Ticlopidine | 1 | 1987 | 730 | 0.010 |
Why?
|
Guanidines | 2 | 1997 | 194 | 0.010 |
Why?
|
RNA, Nuclear | 1 | 2002 | 29 | 0.010 |
Why?
|
Regeneration | 1 | 1991 | 1505 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2635 | 0.010 |
Why?
|
United States | 2 | 2024 | 72339 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22127 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 1996 | 3417 | 0.010 |
Why?
|
Aspartate Aminotransferases | 2 | 1994 | 411 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1988 | 801 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4303 | 0.010 |
Why?
|
RNA, Viral | 2 | 2002 | 2839 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7966 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1988 | 1182 | 0.010 |
Why?
|
Liver Function Tests | 2 | 1994 | 525 | 0.010 |
Why?
|
Glucose Tolerance Test | 2 | 1996 | 1178 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16575 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1838 | 0.010 |
Why?
|
Syndrome | 1 | 1996 | 3271 | 0.010 |
Why?
|
Genetic Variation | 1 | 2014 | 6567 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9055 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1780 | 0.010 |
Why?
|
Brain Injuries | 1 | 2010 | 2054 | 0.010 |
Why?
|
Immunosorbents | 1 | 1998 | 21 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1900 | 0.010 |
Why?
|
Diet | 1 | 2016 | 8048 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1998 | 158 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 2048 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1998 | 359 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1992 | 1624 | 0.010 |
Why?
|
Coronary Disease | 1 | 1992 | 5921 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2009 | 5103 | 0.010 |
Why?
|
Pancytopenia | 1 | 1997 | 102 | 0.010 |
Why?
|
Heparin | 1 | 2004 | 1632 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1076 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1996 | 326 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9979 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1996 | 6504 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1988 | 2244 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1997 | 355 | 0.010 |
Why?
|
Serologic Tests | 1 | 1997 | 381 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1988 | 2157 | 0.010 |
Why?
|
Transplants | 1 | 1998 | 206 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11119 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15545 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10759 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27092 | 0.010 |
Why?
|
Pregnancy | 1 | 1997 | 29893 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1989 | 2263 | 0.010 |
Why?
|
Anemia, Aplastic | 1 | 1997 | 230 | 0.010 |
Why?
|
Kidney Glomerulus | 1 | 1997 | 567 | 0.010 |
Why?
|
Fluorescence | 1 | 1997 | 751 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1998 | 991 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1996 | 606 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5493 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1996 | 1308 | 0.010 |
Why?
|
Fathers | 1 | 1997 | 375 | 0.010 |
Why?
|
Puerperal Disorders | 1 | 1997 | 301 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1994 | 338 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1994 | 410 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1878 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17897 | 0.010 |
Why?
|
Maltose | 1 | 1992 | 39 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1992 | 168 | 0.010 |
Why?
|
Postoperative Period | 1 | 1997 | 1818 | 0.010 |
Why?
|
Child, Preschool | 4 | 1997 | 42224 | 0.010 |
Why?
|
Reference Values | 2 | 1990 | 4921 | 0.010 |
Why?
|
Raffinose | 1 | 1992 | 53 | 0.010 |
Why?
|
Hypertonic Solutions | 1 | 1992 | 82 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2004 | 2746 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1998 | 2569 | 0.010 |
Why?
|
DNA Primers | 1 | 1996 | 2814 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 1993 | 444 | 0.010 |
Why?
|
Ultrasonics | 1 | 1992 | 207 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1996 | 1527 | 0.010 |
Why?
|
Intestinal Absorption | 1 | 1992 | 400 | 0.010 |
Why?
|
Solutions | 1 | 1992 | 410 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1996 | 1624 | 0.010 |
Why?
|
Cross Reactions | 1 | 1993 | 819 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1993 | 1059 | 0.010 |
Why?
|
Secondary Prevention | 1 | 1997 | 1472 | 0.010 |
Why?
|
Lymphography | 1 | 1991 | 188 | 0.010 |
Why?
|
Mesentery | 1 | 1991 | 202 | 0.010 |
Why?
|
Allopurinol | 1 | 1992 | 198 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1996 | 1553 | 0.010 |
Why?
|
Rabbits | 1 | 1996 | 4750 | 0.010 |
Why?
|
Pancreatic Extracts | 1 | 1989 | 6 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1992 | 524 | 0.010 |
Why?
|
DNA, Viral | 1 | 1996 | 2195 | 0.010 |
Why?
|
Glutathione | 1 | 1992 | 581 | 0.010 |
Why?
|
Serum Albumin | 1 | 1992 | 674 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1993 | 1351 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11856 | 0.000 |
Why?
|
Regional Blood Flow | 1 | 1992 | 1498 | 0.000 |
Why?
|
Anticoagulants | 1 | 2004 | 4795 | 0.000 |
Why?
|
Thromboxane A2 | 1 | 1988 | 88 | 0.000 |
Why?
|
Leukocytes | 1 | 1996 | 2025 | 0.000 |
Why?
|
Sugar Phosphates | 1 | 1987 | 44 | 0.000 |
Why?
|
Pan troglodytes | 1 | 1988 | 223 | 0.000 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1989 | 944 | 0.000 |
Why?
|
Adenine Nucleotides | 1 | 1987 | 110 | 0.000 |
Why?
|
Guanosine Triphosphate | 1 | 1988 | 314 | 0.000 |
Why?
|
Plasma Exchange | 1 | 1988 | 159 | 0.000 |
Why?
|
Benzamidines | 1 | 1987 | 20 | 0.000 |
Why?
|
Phosphorylcholine | 1 | 1987 | 153 | 0.000 |
Why?
|
Adenosine | 1 | 1992 | 805 | 0.000 |
Why?
|
Cyclodextrins | 1 | 1987 | 66 | 0.000 |
Why?
|
Erythrocytes | 1 | 1996 | 2413 | 0.000 |
Why?
|
Regression Analysis | 1 | 1996 | 6345 | 0.000 |
Why?
|
Azathioprine | 1 | 1988 | 354 | 0.000 |
Why?
|
Urine | 1 | 1988 | 362 | 0.000 |
Why?
|
Bilirubin | 1 | 1988 | 436 | 0.000 |
Why?
|
Mothers | 1 | 1997 | 2193 | 0.000 |
Why?
|
Lymphocytes | 1 | 1994 | 2603 | 0.000 |
Why?
|
Esters | 1 | 1987 | 210 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1990 | 2468 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1988 | 602 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12404 | 0.000 |
Why?
|
Catheterization, Central Venous | 1 | 1989 | 526 | 0.000 |
Why?
|
Cold Temperature | 1 | 1988 | 783 | 0.000 |
Why?
|
Drug Interactions | 1 | 1989 | 1417 | 0.000 |
Why?
|
Microcirculation | 1 | 1989 | 1280 | 0.000 |
Why?
|
NAD | 1 | 1987 | 612 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17598 | 0.000 |
Why?
|
Atrophy | 1 | 1988 | 1633 | 0.000 |
Why?
|
Blood Proteins | 1 | 1988 | 1173 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1989 | 1988 | 0.000 |
Why?
|
Temperature | 1 | 1987 | 2219 | 0.000 |
Why?
|
Virus Replication | 1 | 1988 | 2426 | 0.000 |
Why?
|
Cholesterol | 1 | 1988 | 2902 | 0.000 |
Why?
|
Mitochondria | 1 | 1992 | 3620 | 0.000 |
Why?
|
Ischemia | 1 | 1987 | 1889 | 0.000 |
Why?
|
Weight Gain | 1 | 1989 | 2349 | 0.000 |
Why?
|
Body Weight | 1 | 1989 | 4618 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1987 | 3770 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1987 | 2877 | 0.000 |
Why?
|
Blood Platelets | 1 | 1987 | 2477 | 0.000 |
Why?
|
Infant | 1 | 1997 | 36169 | 0.000 |
Why?
|